REGENEMED
RegeneMed accelerates the development of safer, more effective drugs by providing integrated high throughput platforms incorporating engineered human tissue-based assays. Their patented, proprietary, core technologies enable in vitro growth of engineered human tissues, including liver, GI tract, bone marrow, blood-brain barrier, cardiovascular and neuronal. The first and critical application of these tissue-based in vitro model systems is to replace cell-based assays and animal testing to debottleneck ADME/Tox evaluation, the leading cause of drug failures facing the pharmaceutical industry.
REGENEMED
Industry:
Biotechnology Health Care
Founded:
2003-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.regenemed.com
Total Employee:
11+
Status:
Active
Contact:
8582009531
Email Addresses:
[email protected]
Total Funding:
1000 K USD
Technology used in webpage:
SPF LetsEncrypt Apache Google Maps HostPapa DNS
Similar Organizations
Gene Sciences, Inc.
Gene Sciences Inc. is developing novel DNA targeted therapeutics for the treatment of human genetic diseases.
Investors List
Tech Coast Angels
Tech Coast Angels investment in Venture Round - RegeneMed
Tech Coast Angels
Tech Coast Angels investment in Venture Round - RegeneMed
Official Site Inspections
http://www.regenemed.com
- Host name: 216.222.197.80
- IP address: 216.222.197.80
- Location: St. Petersburg United States
- Latitude: 27.7728
- Longitude: -82.6379
- Metro Code: 539
- Timezone: America/New_York
- Postal: 33701
